Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN

Nurse Practitioner
Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

Disclosures

Disclosure: Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN, has the following relevant financial relationships:
Other: Advisor or Consultant for: GlaxoSmithKline; Janssen; Karyopharm; Sanofi

Editor

Megan Whitney, DMD

Medical Education Director, Medscape, LLC 

Disclosures

Disclosure: Megan Whitney, DMD, has disclosed no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

CE

Multiple Myeloma Therapy: Optimizing Care for African American Patients

Authors: Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN
CE Released: 2/7/2022
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 2/7/2023, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This activity is intended for hematology/oncology nurses and nurse practitioners (NPs).

The goal of this activity is to improve community-based nurses' knowledge about treatments for multiple myeloma (MM) and disparities in treatment between African American patients and patients of other races/ethnicities.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Updates to the MM treatment paradigm
- Real-world evidence of disparities in health care for African American patients with MM
- Effect of disparities in care on outcomes for African American patients with MM
Demonstrate greater confidence in their ability to
- Identify disparities in health care for their African American patients with MM

Disclosures

Faculty

Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN

Nurse Practitioner
Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

Disclosures

Disclosure: Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN, has the following relevant financial relationships:
Other: Advisor or Consultant for: GlaxoSmithKline; Janssen; Karyopharm; Sanofi

Editor

Megan Whitney, DMD

Medical Education Director, Medscape, LLC 

Disclosures

Disclosure: Megan Whitney, DMD, has disclosed no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Nurses

Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit(s)™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education

Multiple Myeloma Therapy: Optimizing Care for African American Patients

Authors: Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAANFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CE Released: 2/7/2022

Valid for credit through: 2/7/2023, 11:59 PM EST

processing....

Assessment Survey

Before you begin, please take this brief survey.

Page 1 of 4

CE Information Download Slides

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN

Editor

Megan Whitney, DMD

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Peer Reviewer

CE

Multiple Myeloma Therapy: Optimizing Care for African American Patients

Target Audience and Goal Statement

Disclosures

Faculty

Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN

Editor

Megan Whitney, DMD

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Peer Reviewer

Accreditation Statements

For Nurses

Instructions for Participation and Credit

Multiple Myeloma Therapy: Optimizing Care for African American Patients

Assessment Survey

Megan Whitney, DMD

Megan Whitney, DMD